Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-07-07 00:00:00 ET · period of report 2022-07-05 · accession 0001765581-22-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-07 | 2022-07-05 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $157.28 | -8,775 | 354.8K | -2% | -$1.38M |
| D | 2022-07-07 | 2022-07-05 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $46.83 | +9,700 | 360.7K | +3% | +$454.3K |
| D | 2022-07-07 | 2022-07-05 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -9,700 | 9,632 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-07-05 | S | D | 436 | $157.13 | 354,412 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $157.05 to $157.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-07-05 | S | D | 1,000 | $156.95 | 353,412 | D | — | — | |
| 3 | Common | Ordinary Shares | 2022-07-05 | S | D | 1,500 | $160.00 | 351,912 | D | — | — | |
| 4 | Common | Ordinary Shares | 2022-07-05 | M | A | 9,700 | $46.83 | 360,687 | D | — | — | |
| 5 | Common | Ordinary Shares | 2022-07-05 | S | D | 5,839 | $156.65 | 354,848 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $156.05 to $157.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-07-05 | M | D | 9,700 | $0.00 | 9,632 | D | $46.83 · — to 2022-08-08 | 9,700 Ordinary Shares | (F5) This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016. |